Mindfulness-based stress reduction for treating chronic headache: A systematic review and meta-analysis.
Study Goal
The researchers aimed to assess the efficacy and safety of mindfulness-based stress reduction/cognitive therapy in reducing symptoms of chronic headache.
Results Summary
The study found no significant improvement in headache frequency, duration, or intensity compared to usual care. The results were imprecise due to the small scale, low number of trials, and high or unclear risk of bias.
Population
Adults with chronic headache (migraine, tension-type headache, or mixed samples).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based stress reduction/cognitive therapy | no change | headache frequency | participants with chronic headache | standardized mean difference = 0.00; 95% confidence interval = -0.33,0.32 | did not improve | #1 |
mindfulness-based stress reduction/cognitive therapy | no change | headache duration | participants with chronic headache | standardized mean difference = -0.08; 95% confidence interval = -1.03,0.87 | did not improve | #2 |
mindfulness-based stress reduction/cognitive therapy | no change | pain intensity | participants with chronic headache | standardized mean difference = -0.78; 95% confidence interval = -1.72,0.16 | no significant difference between groups was found for | #3 |
BACKGROUND: Mindfulness-based stress reduction/cognitive therapy are frequently used for pain-related conditions, but their effects on headache remain uncertain. This review aimed to assess the efficacy and safety of mindfulness-based stress reduction/cognitive therapy in reducing the symptoms of chronic headache. DATA SOURCES AND STUDY SELECTION: MEDLINE/PubMed, Scopus, CENTRAL, and PsychINFO were searched to 16 June 2017. Randomized controlled trials comparing mindfulness-based stress reduction/cognitive therapy with usual care or active comparators for migraine and/or tension-type headache, which assessed headache frequency, duration or intensity as a primary outcome, were eligible for inclusion. Risk of bias was assessed using the Cochrane Tool. RESULTS: Five randomized controlled trials (two on tension-type headache; one on migraine; two with mixed samples) with a total of 185 participants were included. Compared to usual care, mindfulness-based stress reduction/cognitive therapy did not improve headache frequency (three randomized controlled trials; standardized mean difference = 0.00; 95% confidence interval = -0.33,0.32) or headache duration (three randomized controlled trials; standardized mean difference = -0.08; 95% confidence interval = -1.03,0.87). Similarly, no significant difference between groups was found for pain intensity (five randomized controlled trials; standardized mean difference = -0.78; 95% confidence interval = -1.72,0.16). CONCLUSIONS: Due to the low number, small scale and often high or unclear risk of bias of included randomized controlled trials, the results are imprecise; this may be consistent with either an important or negligible effect. Therefore, more rigorous trials with larger sample sizes are needed.